Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0458 Transporter Info | ||||
Gene Name | SLC6A6 | ||||
Transporter Name | Sodium- and chloride-dependent taurine transporter | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 9 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A6 gene in glioblastoma multiforme condition | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) has been reported to repress the transcription of SLC6A6 gene in glioblastoma multiforme condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
BACH2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Transcription regulator protein BACH2 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription regulator protein BACH2 (BACH2) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
FOSL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Fos-related antigen 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Fos-related antigen 1 (FOSL1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
JUN |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in acute kidney injury condition | [6] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Affected Drug/Substrate |
Cisplatin | |||||
Studied Phenotype |
Acute kidney injury [ICD11: GB60] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Madin-Darby canine kidney cells (MDCK) | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to activate the transcription of SLC6A6 gene in acute kidney injury condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Repression of SLC6A6 gene in health condition | [7] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human kidney human embryonic kidney 293 cells (HEK 293) | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to repress the transcription of SLC6A6 gene in health condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
JUNB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Transcription factor JunB | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunB (JUNB) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
JUND |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in coronary artery disease condition | [8] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor JunD (JUND) has been reported to bind to the transcription of SLC6A6 gene in coronary artery disease condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Breast; Cervix; Colon; Coronary artery; Embryo; Liver; Lung; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 10 TF(s) Regulating This DT |
|||||
ARNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
BHLHE40 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Class E basic helix-loop-helix protein 40 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Class E basic helix-loop-helix protein 40 (BHLHE40) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
CLOCK |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in colorectal cancer condition | [9] | ||||
TF Protein Name |
Circadian locomoter output cycles protein kaput | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Circadian locomoter output cycles protein kaput (CLOCK) has been reported to activate the transcription of SLC6A6 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
MXI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Max-interacting protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Max-interacting protein 1 (MXI1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A6 gene in Burkitt lymphoma condition | [10] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to repress the transcription of SLC6A6 gene in Burkitt lymphoma condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Embryo; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
TCF21 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in coronary artery disease condition | [8] | ||||
TF Protein Name |
Transcription factor 21 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 21 (TCF21) has been reported to bind to the SLC6A6 gene in coronary artery disease condition, which affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
TFAP4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Transcription factor AP-4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-4 (TFAP4) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Embryo; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TFAP2C |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in breast cancer condition | [11] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) has been reported to activate the transcription of SLC6A6 gene in breast cancer condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in prostate cancer condition | [12] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC6A6 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
ESR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Estrogen receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Estrogen receptor (ESR1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
NR1H3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in atherosclerotic condition | [13] | ||||
TF Protein Name |
Oxysterols receptor LXR-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Oxysterols receptor LXR-alpha (NR1H3) has been reported to activate the transcription of SLC6A6 gene in atherosclerotic condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
PPARG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in health condition | [14] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Placenta | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human primary placental trophoblast cell isolates | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG) has been reported to activate the transcription of SLC6A6 gene in health condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
RARG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Retinoic acid receptor gamma | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Retinoic acid receptor gamma (RARG) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
RXRG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Retinoic acid receptor RXR-gamma | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Retinoic acid receptor RXR-gamma (RXRG) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
VDR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in THP1 cells | [15] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to bind to the transcription of SLC6A6 gene in THP1 cells, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 15 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
EGR1 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in tumorigenic prostate condition | [16] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to activate the transcription of SLC6A6 gene in tumorigenic prostate condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Binding to SLC6A6 gene in erythroleukemia condition | [17] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC6A6 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon3 |
Activation of SLC6A6 gene in defective renal development condition | [18] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Defective renal development [ICD11: LB30] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Rat Kidney epithelial cells (NRK-52E) | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to activate the transcription of SLC6A6 gene in defective renal development condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Foreskin; Pancreatic ductal; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
SP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Transcription factor Sp1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Colon; Embryo; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor Sp1 (SP1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
WT1 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in podocyte condition | [19] | ||||
TF Protein Name |
Wilms tumor protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Wilms tumor protein (WT1) has been reported to activate the transcription of SLC6A6 gene in podocyte condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Activation of SLC6A6 gene in defective renal development condition | [18] | ||||
TF Protein Name |
Wilms tumor protein | Transcription Factor Info | ||||
Studied Phenotype |
Defective renal development [ICD11: LB30] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Cats | |||||
Detailed Description |
Wilms tumor protein (WT1) has been reported to activate the transcription of SLC6A6 gene in defective renal development condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon3 |
Repression of SLC6A6 gene in health condition | [7] | ||||
TF Protein Name |
Wilms tumor protein | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human kidney human embryonic kidney 293 cells (HEK 293) | |||||
Detailed Description |
Wilms tumor protein (WT1) has been reported to repress the transcription of SLC6A6 gene in health condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
YY1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Colon; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in breast cancer condition | [20] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC6A6 gene in breast cancer condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
ZNF384 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Zinc finger protein 384 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 384 (ZNF384) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
ZNF83 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Zinc finger protein 83 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 83 (ZNF83) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
POU2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
POU domain, class 2, transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
POU domain, class 2, transcription factor 1 (POU2F1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
ZEB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Zinc finger E-box-binding homeobox 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger E-box-binding homeobox 1 (ZEB1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 9 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Embryo; Endoderm; Liver; Lung; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
FOXK1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Forkhead box protein K1 | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein K1 (FOXK1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
FOXO3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in tumorigenesis condition | [21] | ||||
TF Protein Name |
Forkhead box protein O3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein O3 (FOXO3) has been reported to activate the transcription of SLC6A6 gene in tumorigenesis condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
FOXP1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A6 gene in embryonic stem cell condition | [22] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) has been reported to repress the transcription of SLC6A6 gene in embryonic stem cell condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
FOXP2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in health condition | [23] | ||||
TF Protein Name |
Forkhead box protein P2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Forkhead box protein P2 (FOXP2) has been reported to bind to the transcription of SLC6A6 gene in health condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
RFX5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
DNA-binding protein RFX5 | Transcription Factor Info | ||||
Tissue |
Cervix; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
DNA-binding protein RFX5 (RFX5) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
ELF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
ETS-related transcription factor Elf-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Breast; Liver; Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS-related transcription factor Elf-1 (ELF1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Lung; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
FLI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in megakaryocytes condition | [24] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of SLC6A6 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Umbilical cord blood; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Breast; Cervix; Liver; Lung; Mesenchymal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
MYB |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A6 gene in health condition | [7] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human kidney human embryonic kidney 293 cells (HEK 293) | |||||
Detailed Description |
Transcriptional activator Myb (MYB) has been reported to repress the transcription of SLC6A6 gene in health condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
SPI1 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in K562 cells | [25] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC6A6 gene in K562 cells, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Binding to SLC6A6 gene in acute myeloid leukemia condition | [26] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC6A6 gene in acute myeloid leukemia condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon3 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
SPIB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Transcription factor Spi-B | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor Spi-B (SPIB) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class4.2: Heteromeric CCAAT-binding factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFYA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
Nuclear transcription factor Y subunit alpha | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear transcription factor Y subunit alpha (NFYA) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class5.1: MADS box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
MEF2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Myocyte-specific enhancer factor 2A | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myocyte-specific enhancer factor 2A (MEF2A) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
NFAT5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in hyposmolality condition | [27] | ||||
TF Protein Name |
Nuclear factor of activated T-cells 5 | Transcription Factor Info | ||||
Studied Phenotype |
Hyposmolality [ICD11: 5C72] | |||||
Tissue |
Thymus | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Sprague-Dawley rats | |||||
Detailed Description |
Nuclear factor of activated T-cells 5 (NFAT5) has been reported to activate the transcription of SLC6A6 gene in hyposmolality condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
RBPJ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in immortal lymphoblast cell lines (LCLs) condition | [28] | ||||
TF Protein Name |
Recombining binding protein suppressor of hairless | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Recombining binding protein suppressor of hairless (RBPJ) has been reported to bind to the transcription of SLC6A6 gene in immortal lymphoblast cell lines (LCLs) condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in fibrosarcoma condition | [29] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to activate the transcription of SLC6A6 gene in fibrosarcoma condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC6A6 gene in acute kidney injury condition | [6] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Cisplatin | |||||
Studied Phenotype |
Acute kidney injury [ICD11: GB60] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Madin-Darby canine kidney cells (MDCK) | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC6A6 gene in acute kidney injury condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon2 |
Repression of SLC6A6 gene in defective renal development condition | [18] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
Defective renal development [ICD11: LB30] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Cats | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC6A6 gene in defective renal development condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Transcriptional Phenomenon3 |
Repression of SLC6A6 gene in health condition | [7] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human kidney human embryonic kidney 293 cells (HEK 293) | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC6A6 gene in health condition, which leads to a decreased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in epithelial to mesenchymal transition condition | [30] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC6A6 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A6 gene in megakaryocytes condition | [24] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC6A6 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A6 gene in prostate cancer condition | [31] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC6A6 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [4] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class8.1: TATA-binding proteins |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TBP |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [5] | ||||
TF Protein Name |
TATA-box-binding protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
TATA-box-binding protein (TBP) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
MBD3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [2] | ||||
TF Protein Name |
Methyl-CpG-binding domain protein 3 | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Methyl-CpG-binding domain protein 3 (MBD3) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
Class10.5: GTF2I domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GTF2I |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A6 gene | [3] | ||||
TF Protein Name |
General transcription factor II-I | Transcription Factor Info | ||||
Tissue |
Foreskin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
General transcription factor II-I (GTF2I) can directly bind to the SLC6A6 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent taurine transporter. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.